The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study
Frontiers in Cardiovascular Medicine · 30.10.2026 · 13
DOI: 10.3389/fcvm.2026.1955087 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 30.10.2026. Verfasst von Jing Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with ST-segment-elevation myocardial infarction (STEMI) without standard modifiable cardiovascular risk factors (SMuRFs) exhibit paradoxically increased mortality. We aimed to characterize associations with adverse outcomes and identify potential drivers.
Methods
We included patients with STEMI from a hospital-based cohort in Lanzhou, China ( n = 6,892; 2014–2023) and the US Medical Information Mart for Intensive Care IV (MIMIC-IV; n = 4,480; 2008–2019). SMuRF-less status was defined as the absence of hypertension, diabetes, hyperlipidemia, and smoking, with obesity included in sensitivity analyses. Primary outcomes were 30- and 365-day all-cause mortality. Secondary outcomes were major adverse cardiac and cerebrovascular events (MACCEs), 7-day delirium and acute kidney injury (AKI). Associations were estimated using adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs), and Fine–Gray competing-risk analyses performed for 7-day delirium and AKI.
Results
SMuRF-less patients comprised 17.2% ( n = 1,182) of the Lanzhou cohort and 13.6% ( n = 608) of the MIMIC-IV cohort. SMuRF-less status was associated with higher 30-day mortality in both cohorts (Lanzhou: aHR, 1.37; 95% CI, 1.09–1.71; MIMIC-IV: 1.67, 1.39–2.01). In landmark analyses, SMuRF-less status was not significantly associated with mortality during days 31–365 in Lanzhou (1.68; 0.84–3.37) but was associated with higher mortality in MIMIC-IV (1.34; 1.02–1.77). SMuRF-less status was not significantly associated with MACCEs in Lanzhou. In MIMIC-IV, SMuRF-less status was associated with a higher risk of 7-day delirium (1.40; 1.17–1.67) but was not associated with 7-day AKI (1.05; 0.94–1.17). For both 7-day delirium and AKI, competing-risk analyses yielded consistent findings. In subgroup analyses, excess 30-day mortality was greater among patients in Lanzhou not receiving extracorporeal membrane oxygenation, those not receiving intra-aortic balloon pump, and those with Killip class I–III ( P for interaction <0.05). Sensitivity analyses incorporating obesity showed similar associations for 30-day mortality in Lanzhou (1.40; 1.12–1.76) and MIMIC-IV (1.63; 1.33–1.99), as well as for 7-day delirium (1.33; 1.09–1.62).
Conclusions
SMuRF-less status was independently associated with increased early mortality in both cohorts and a higher risk of delirium in the MIMIC-IV cohort. This excess risk was not fully explained by measured clinical and physiological markers, suggesting that residual risk may extend beyond conventional modifiable cardiovascular risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
- Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, China.
- Gansu Province Clinical Research Centre for Cardiovascular Diseases, The First Hospital of Lanzhou University, Lanzhou, China.
- Shanghai-MOST Key Laboratory of Health and Disease Genomics, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
- Clinical Research Center, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zitieren
APA
Zhao, J., Wei, J., Pan, C., Peng, Y., Lei, P., Lian, Q., Lyu, J., Bai, M., & Zhang, Z. (2026). The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1955087
Vancouver
Zhao J, Wei J, Pan C, Peng Y, Lei P, Lian Q, et al. The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1955087
BibTeX
@article{Zhao2026,
author = {Zhao, Jing and Wei, Junchu and Pan, Chenliang and Peng, Yu and Lei, Peng and Lian, Qiguo and Lyu, Jun and Bai, Ming and Zhang, Zheng},
title = {The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1955087}
}
EUVIMED